WeVote
Log In

Bill

Bill

LC 2083

Revise laws related to state purchase of opioid antagonists

2025 Regular Session

Montana bill revising state opioid antagonist purchasing laws to clarify emergency drug availability during overdose crises.

(LC) Draft in Assembly
#alcoholanddrugs #publiccontracts(seealso:contracts) #rulemaking
0
WeVote Research Nonpartisan
Bill Summary · LC 2083

Legislative bill overview

Bill LC 2083 proposes revisions to Montana's laws governing state purchase and distribution of opioid antagonists (such as naloxone/Narcan). The bill is currently in early drafting stages and has not yet been formally introduced for legislative consideration. The specific provisions are not publicly available as the bill remains under legal review and editing.

Why is this important

Opioid antagonists are critical emergency medications that can reverse opioid overdoses and save lives. How states structure purchasing, storage, and distribution of these drugs directly affects accessibility during overdose emergencies—particularly in rural areas and among vulnerable populations. Clarifying state purchase authority can either expand or limit availability depending on the bill's final language.

Potential points of contention

  • Cost and budget allocation: Disagreement over whether state funds should subsidize opioid antagonist purchases versus relying on healthcare providers, pharmacies, or federal grant programs
  • Distribution scope: Debate about whether antagonists should be stocked only in hospitals/emergency services or expanded to schools, public spaces, law enforcement, and community organizations
  • Access vs. liability concerns: Tension between maximizing availability to prevent deaths and concerns about legal liability, proper training, and appropriate use protocols

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.